scholarly journals “A COMPARATIVE STUDY OF FINANCIAL ANALYSIS OF CADILA AND TORRENT PHARMACUTICALS IN GUJRAT STATE”

2020 ◽  
pp. 1-10
Author(s):  
Bhavsinh Dodiya
Keyword(s):  
Comparative Analysis ◽  
Financial Analysis ◽  
Market Price ◽  
Pharmaceutical Companies ◽  
Financial Status ◽  
Social Responsibilities ◽  
Other Information ◽  
Corporate Social ◽  
Current Market Price ◽  
A Current

Estimation of any company real worth is made by the earnings which depend on investments, quality goods, competitiveness, expertise, quality management of company, profitability, capital structure and dividend policy, corporate social responsibilities. For investing in any company many people use a comparative analysis or financial performances of last data to make their buy or sell decisions. We do this because we need to examine a current market price is fair or not. Investor should analyse management, product, strategy, economy, financial status and other information will help to choose that invest or not. Here attempt madeto analyze the comparative analysis through analysis of financial performance of 2 pharmaceutical companies by using a ratio analysis.

Comparative analysis of business models of top pharmaceutical manufacturing companies: fifi nancial analysis

2020 ◽  
pp. 43-52
Author(s):  
L.E. Yasinskaya ◽  
Keyword(s):  
Comparative Analysis ◽  
Business Models ◽  
Financial Analysis ◽  
Active Pharmaceutical Ingredient ◽  
Pharmaceutical Companies ◽  
Manufacturing Companies ◽  
Revenue Growth ◽  
Commercial Activities ◽  
Pharmaceutical Manufacturers ◽  
Research Procedure

Introduction. Earlier, the comparative analysis of the commercial and investment activities of the companies that play the key roles in the investment processes in the Russian pharmaceutical industry and operate within the four main business models (biotechnological, generic, specialized pharmaceutical companies, active pharmaceutical ingredient (API) manufacturers) has been conducted. No full assessment of the companies’ activitiesis conceivable without a financial analysis of their activities to identify the risks of investment activities. Objective of the study. A detailed comparative analysis of the financial standing of domestic pharmaceutical manufacturers operating within the selected business models for further identification of potential financial risks for investors. Research procedure and article structure. Analysis of RAS statements (forms 1 and 2) of 72 over 500 million revenue companies grouped together as selected business models for the period from 2015 to 2019. Results. The researchers provided a detailed description of the commercial activities of domestic pharmaceutical companies within the business models under consideration. The companies within various business models showed positive revenue growth rates over the past five years. All business models demonstrate consistently high business profitability and a significant share of own capital in the asset profile. Conclusion. The results of the study show the stable financial standing of the pharmaceutical companies within various business models. The biotechnology sector companies that are the most attractive for investments have the highest quality financial standing. The specialized and generic companies show similar consistently strong performance. API manufacturers that the companies with relatively small revenues are actively developing and are attractive to restrained budget investors.

scholarly journals ANALYSIS OF THE FINANCIAL CONDITION OF ENTERPRISES BY PHASES OF THEIR LIFE CYCLE

2018 ◽  
Vol 1 (2(14)) ◽  
pp. 31-38
Author(s):  
Tetjana Mykolaivna Kovalchuk ◽  
Andrij Ivanovych Vergun
Keyword(s):  
Life Cycle ◽  
Comparative Analysis ◽  
Financial Analysis ◽  
Methodological Approach ◽  
Decision Makers ◽  
Target Setting ◽  
Financial Status ◽  
Financial Condition ◽  
Administrative Tasks ◽  
Integral Indicator

Urgency of the research. Solving administrative tasks related to the ranking of enterprises according to their financial condition predetermines the objective need to use methodical tools of financial analysis. Target setting. An important factor in the financial situation that needs to be taken into account when developing the analysis techniques to ensure the comparability of enterprises is the phase of their lifecycle. Actual scientific researches and issue analysis. Scientists such as L. Bernstein, G. Foster, E. Helfert, J. Wild, K. R. Subramanyam and others made a significant contribution to the development of methods for analyzing the indicators of financial status. Univestigated parts of general matters defining. At the same time, little attention is paid to the issue of developing a method of comparative analysis of the financial condition of the phases of the enterprise's life cycle. The research objective. The substantiation of the method of comparative analysis of the financial condition of enterprises, taking into account the phases of their life cycle on the basis of the method of analysis of hierarchies. The statement of basic materials. The method of analysis of hierarchies developed a method of comparative analysis of the financial condition of enterprises located at different phases of the life cycle. Conclusions. The use of this methodological approach allows you to take into account such an important factor in the financial condition of the enterprise as the phase of its life cycle and to provide decision-makers with a reasonable criterion as an integral indicator for the analysis of enterprises at different stages of development. A comparative analysis of the financial condition on the basis of the proposed methodology can be carried out within the framework of strategic financial analysis and analysis of investment attractiveness of enterprises.

scholarly journals Pharmaceutical Industry’s Engagement in the Global Equitable Distribution of COVID-19 Vaccines: Corporate Social Responsibility of EUL Vaccine Developers

Vaccines ◽  
2021 ◽  
Vol 9 (10) ◽  
pp. 1183
Author(s):  
Meekang Sung ◽  
Yangmu Huang ◽  
Yuqi Duan ◽  
Fangjing Liu ◽  
Yinzi Jin ◽  
...  
Keyword(s):  
Corporate Social Responsibility ◽  
Social Responsibility ◽  
Vaccine Delivery ◽  
Pharmaceutical Companies ◽  
Social Responsibilities ◽  
Intellectual Property Management ◽  
The Status ◽  
Corporate Social ◽  
Vaccine Distribution ◽  
Lower Income Countries

(1) Objectives: Inequality in the global distribution of COVID-19 vaccines has brought about great challenges in terms of resolving the pandemic. Although vaccine manufacturers are undoubtedly some of the most influential players, studies on their role in global vaccine distribution have been scarce. This study examined whether the pharmaceutical industry is acting according to the principles of corporate social responsibility (CSR) during the pandemic. (2) Methods: Three categories were used to analyze the CSR of vaccine developers. The first was research and development: effectiveness, funding, and profits were measured. The second was transparency and accountability: the transparency of clinical trials and vaccine contracts was analyzed. The final was vaccine delivery: the status of the provision of vaccines to COVAX and lower-income countries, intellectual property management, manufacturing agreements, and equitable pricing were measured. (3) Results: Vaccine developers have acquired large profits. The vaccine delivery category faces the most challenges. Participation of pharmaceutical companies through COVAX was significantly low, and most vaccine supply agreements were secretive, bilateral deals. It was not clear if companies were maintaining equitable pricing. The evaluation indicated that the companies’ CSR practices have differed during the pandemic. (4) Conclusions: Our study contributes to the methodology of assessing the CSR of vaccine developers. This would help understand the current COVID-19 vaccine distribution inequality and propose that pharmaceutical companies re-examine their roles and social responsibilities.

The Effect of Internal Corporate Social Responsibility on Job Satisfaction: An Empirical Study on Jordanian Pharmaceutical Companies

2020 ◽  
Vol 8 (2) ◽  
pp. 112
Author(s):  
Sura Altheeb ◽  
Kholoud Sudqi Al-Louzi
Keyword(s):  
Job Satisfaction ◽  
Corporate Social Responsibility ◽  
Social Responsibility ◽  
Quantitative Research ◽  
Skills Development ◽  
Future Research ◽  
Pharmaceutical Companies ◽  
Corporate Social ◽  
The Impact ◽  
Positive Results

The current research investigates the impact of internal corporate social responsibility on job satisfaction in Jordanian pharmaceutical companies. Quantitative research design and regression analysis were applied on a total of 302 valid returns that were obtained in a questionnaire based survey from 14 pharmaceutical companies among employees, supervisors and managers. The results showed that internal corporate social responsibility was significantly related to job satisfaction and three of its dimensions, namely working conditions, work life balance and empowerment contributed significantly to job satisfaction, whereas employment stability and skills development had no contribution. This study implies that Jordanian pharmaceutical companies have to try their best to promote and facilitate internal corporate social responsibility among their employees in an effort to improve their job satisfaction, which will eventually yield positive results for the company as a whole. In light of these results, the research presented many recommendations for future research; the most important ones were the application of this study in other sectors, cultures, and countries, and using of multi method for collecting data.

Evaluating the Financial Performance Through ‘Consumer Centric Decision’ Approach in Pharmaceutical Companies of Bangladesh: a Business Planning Perspective

2017 ◽  
Vol 9 (1) ◽  
pp. 168
Author(s):  
Md Mostafizur Rahman ◽  
Mahmud Uz Zaman
Keyword(s):  
Market Share ◽  
Swot Analysis ◽  
Financial Analysis ◽  
Pharmaceutical Companies ◽  
Short Term ◽  
The Public ◽  
Investment Choice ◽  
Good Investment ◽  
Business Analysis

Pharmaceuticals agglomerations consistently use their brand image and versatile product portfolios to consolidate their position in the financial sector, which is evident in their continuous profit making and expansion in market share. This paper explores the short-term and long-term investment attractiveness through ‘consumer centric decision’ approach in two selected pharmaceutical companies, Renata Limited and Orion Pharma Limited, of Bangladesh over the last three years’ period. This research adopts a systematic approach which primarily addresses the various concerns of investors to illustrate the decision-making process of the existing and future investors. Using primarily domestic transaction data, this study explores how the leading pharmaceuticals companies of Bangladesh effectively use the wide array of drug portfolios mix with appropriate branding techniques to increase their financial profit and market share simultaneously. Both SWOT analysis and Porters Five Forces Model explore the business analysis of Renata Limited in compare to Orion Pharma Limited that provides a conclusion regarding investors’ decision to invest in Renata Limited. Considering the financial analysis, Renata’s financial liquidity is not very satisfactory and could have been improved further if management is prudent on financial strategy settings. Findings of the business analysis indicate that Renata Limited would be a good investment choice for existing and prospective shareholders based on its opportunities for long term and short term growth and further expansion in developing the market. The results suggest that even lower liquidity coupled with higher interest borrowings can be balanced by posing positive picture to the public shareholders by returning the positive dividend to them.

scholarly journals The Effects of CSR Activities on Business According to Employee Perception

2021 ◽  
pp. 1-22
Author(s):  
Anđelka Stojanović ◽  
Natalija Sofranova ◽  
Sanela Arsić ◽  
Isidora Milošević ◽  
Ivan Mihajlović
Keyword(s):  
Job Satisfaction ◽  
Factor Analysis ◽  
Corporate Social Responsibility ◽  
Comparative Analysis ◽  
Confirmatory Factor Analysis ◽  
Confirmatory Factor ◽  
Different Dimensions ◽  
Corporate Social ◽  
Vital Element

Corporate social responsibility (CSR) has become a vital element for building a long-term relationship with a company’s stakeholders. Different dimensions of a company’s social initiatives in terms of internal and external CSR activities influence the satisfaction of employees with the purpose of improving the CSR application. The aim of this research is to examine the level of employees’ awareness of the implementation of CSR in Serbian and Russian companies. A comparative analysis between these two countries was carried out in order to perceive the differences in attitudes of employees, their job satisfaction, and consequently the implementation of CSR. The hypotheses of the developed model were tested by using the Multi-group Confirmatory Factor Analysis. The obtained results offered several implications for scholars and practitioners that should be considered when formulating and implementing CSR actions.

Sign in / Sign up

Export Citation Format

Share Document